The office of Novartis near Basel, Switzerland. Reuters
Swiss drugmaker Novartis on won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. The Food and Drug Administration approved Zolgensma for children
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
Despite strong legislations, India still grapples with the malaise of counterfeit medicines being sold in the open market and online. In fact I recently came across a report which said that about 20 per cent of the drugs manufactured in India are adulterated. It is an unhealthy prognosis but apart from that India
Confirmation of a new Brexit deal sent sterling to a five-month high on Thursday and hoisted European stocks to a year-and-a-half peak, before familiar doubts about British parliamentary support for the agreement hauled them back.
Emirates NBD Bank on Thursday announced that it proposes to raise Dhs6.45 billion via a rights share offering to strengthen its capital base and support the future growth of the business.
The Abu Dhabi National Oil Company (Adnoc), Adani Group, BASF SE and Borealis AG have signed a Memorandum of Understanding, MoU, to engage in a joint feasibility study to further evaluate a collaboration